Efficacy of cinacalcet in hyperparathyroidism after renal transplantation.
Completed
- Conditions
- open label observational study during 8 months in approx 20 renal transplant patients
- Registration Number
- NL-OMON24309
- Lead Sponsor
- Renal Transplant UnitAcademic Medical Center
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
1. Hypercalciemia more than 2,60 mmol/l;
2. Elevated iPTH plasma levels more than 15 pmol/l;
Exclusion Criteria
1. Antirejection therapy less than 4 weeks; prior to inclusion;
2. Pregnancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ormalisation of serum calcium and parathormon at six months.
- Secondary Outcome Measures
Name Time Method Reduced and sustained parathormon activity after withdrawal of cinacalcet.